EWG Elevate’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28,000
| Closed | -$480K | – | 121 |
|
|
2024
Q4 | $480K | Buy |
+28,000
| New | +$480K | 0.15% | 99 |
|
|
2024
Q3 | – | Sell |
-70,000
| Closed | -$783K | – | 114 |
|
|
2024
Q2 | $783K | Sell |
70,000
-30,000
| -30% | -$335K | 0.29% | 74 |
|
|
2024
Q1 | $660K | Buy |
100,000
+50,000
| +100% | +$330K | 0.25% | 78 |
|
|
2023
Q4 | $226K | Buy |
50,000
+25,000
| +100% | +$113K | 0.09% | 95 |
|
|
2023
Q3 | $89.5K | Sell |
25,000
-39,000
| -61% | -$140K | 0.04% | 93 |
|
|
2023
Q2 | $236K | Sell |
64,000
-36,000
| -36% | -$133K | 0.1% | 85 |
|
|
2023
Q1 | $331K | Buy |
+100,000
| New | +$331K | 0.14% | 66 |
|
|
2022
Q4 | – | Sell |
-121,000
| Closed | -$294K | – | 834 |
|
|
2022
Q3 | $294K | Buy |
121,000
+21,000
| +21% | +$51K | 0.17% | 58 |
|
|
2022
Q2 | $198K | Hold |
100,000
| – | – | 0.1% | 73 |
|
|
2022
Q1 | $183K | Buy |
+100,000
| New | +$183K | 0.07% | 89 |
|